Clinical Trials Logo

Filter by:
NCT ID: NCT05968664 Not yet recruiting - Chronic Pain Clinical Trials

Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this study is to compare pain outcomes achieved by spinal cord stimulation (SCS) using time varying stimulation patterns with pain outcomes achieved by current standard of care SCS.

NCT ID: NCT05967494 Not yet recruiting - Clinical trials for Chronic Fatigue Syndrome

Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences

Start date: August 2024
Phase:
Study type: Observational

The study seeks to delve into the firsthand experiences of patients diagnosed with chronic fatigue syndrome who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all chronic fatigue syndrome patients as well as those in under-represented demographic groups.

NCT ID: NCT05967481 Not yet recruiting - Clinical trials for Neuroendocrine Tumors

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Start date: August 2024
Phase:
Study type: Observational

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.

NCT ID: NCT05967364 Not yet recruiting - Suicide Clinical Trials

Career Enhancement Training Study Delivered Across Career Phases

Start date: July 2024
Phase: N/A
Study type: Interventional

This trial tests the effectiveness of the Wingman-Connect Program delivered by USAF personnel on individual suicide risk. Randomization will be among classes at Initial Technical Training, in which 396 classes of USAF personnel will be randomized to Wingman-Connect or to an active control training (N=2,970 Airmen) and followed for one year. These classes send a proportion of graduates to Air Force Global Strike Command (AFGSC) & Air Mobility Command (AMC) operational bases.

NCT ID: NCT05967273 Not yet recruiting - Cirrhosis Clinical Trials

CirrhosisRx CDS System

Start date: July 2024
Phase: N/A
Study type: Interventional

The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.

NCT ID: NCT05965713 Not yet recruiting - Stroke Clinical Trials

National Fully Remote Use of IpsiHand Device in Hemiparetic Stroke

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to define the efficacy of fully remote home-based BCI therapy in chronic hemiparetic subcortical stroke patients. A randomized controlled study using the integrated remote BCI system will be tested against standard exercise therapy to determine the efficacy of motor improvement in chronic stroke patients with an upper extremity hemiparesis. Specifically, the integrated BCI system will include 1) the remote screening and motor assessment system for the upper extremity and 2) the BCI-controlled robotic hand exoskeleton (i.e. IpsiHand).

NCT ID: NCT05962788 Not yet recruiting - Clinical trials for Adolescent Lupus Nephritis

Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis

VOCAL-EXT
Start date: March 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the long-term safety and tolerability of voclosporin for up to an additional 12 months following completion of treatment in the AUR-VCS-2020-03 study (VOCAL) in adolescents with active lupus nephritis.

NCT ID: NCT05962697 Not yet recruiting - Acute Stroke Clinical Trials

An Upper Extremity Exoskeleton to Target Unwanted Joint Synergies During Repetitive Training in Stroke Survivors

Start date: August 3, 2024
Phase: N/A
Study type: Interventional

Stroke is the leading cause of adult-onset disability, and affects 15,000 Veterans each year. Successful rehabilitation and recovery following a stroke requires therapy including repetitive task training. However, repetitive task training can be draining for both the clinician and the patient as it requires the participant to complete many repetitions of the same task and those repetitions can be difficult to accomplish with appropriate technique. Robot-mediated repetitive task training has the potential to facilitate the clinical delivery of proven rehabilitation programs to Veterans in need and recently a new exoskeleton has been developed, called Harmony, which can deliver bimanual 3D arm therapy. The investigators propose to develop and test two novel controllers', synergy avoidance and task assistance, that use promising neurological basis for training to facilitate repetitive task training while ensuring correct movement patterns in acute and sub-acute stage stroke patients. This has the potential to improve Veterans' activities of daily living and quality of life.

NCT ID: NCT05962242 Not yet recruiting - Clinical trials for Squamous Cell Carcinoma of the Oropharynx

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

HN001
Start date: January 1, 2024
Phase: Phase 2
Study type: Interventional

The study will evaluate the safety and effectiveness of a lower than standard dose of radiation for definitive or adjuvant treatment of head and neck squamous cell carcinomas.

NCT ID: NCT05962229 Not yet recruiting - Nicotine Dependence Clinical Trials

Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine

Start date: June 1, 2024
Phase: Phase 1
Study type: Interventional

In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment.